2,5-Dimethoxy-4-isobutylamphetamine
Chemical compound
2,5-Dimethoxy-4-isobutylamphetamine | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
2,5-Dimethoxy-4-isobutylamphetamine (DOIB) is a psychedelic phenethylamine of the substituted amphetamines class. It is a synthetic compound that is structurally related to other psychedelic phenethylamines such as 2C-B and DOB.
Chemical Structure and Properties[edit | edit source]
DOIB is a derivative of amphetamine and is characterized by the presence of two methoxy groups at the 2 and 5 positions of the phenyl ring, and an isobutyl group at the 4 position. The chemical formula of DOIB is C15H25NO2, and it has a molecular weight of 251.37 g/mol.
Pharmacology[edit | edit source]
DOIB acts primarily as a serotonin receptor agonist, particularly at the 5-HT2A receptor, which is believed to be responsible for its psychedelic effects. The compound is known to produce alterations in perception, mood, and cognition, similar to other psychedelics.
Effects[edit | edit source]
The effects of DOIB are similar to those of other psychedelic amphetamines, such as DOM and DOB. Users report visual and auditory hallucinations, altered sense of time, and changes in thought processes. The onset of effects typically occurs within 1 to 2 hours after ingestion, with the duration lasting up to 12 hours.
Synthesis[edit | edit source]
The synthesis of DOIB involves the alkylation of 2,5-dimethoxyphenethylamine with isobutyl bromide. This process requires careful control of reaction conditions to ensure the correct substitution pattern on the aromatic ring.
Legal Status[edit | edit source]
DOIB is not widely used and is not specifically listed as a controlled substance in many countries. However, it may be considered an analogue of other controlled substances, making it potentially subject to analogue laws.
Related Compounds[edit | edit source]
DOIB is part of a family of compounds that includes other substituted amphetamines such as DOB, DOI, and DOM. These compounds share a common structural motif and are known for their potent psychedelic effects.
See Also[edit | edit source]
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD